🔎 Trials Near Me

Hjem › Pulmonal hypertensjon › Illinois

Kliniske studier for Pulmonal hypertensjon i Illinois

6 studier for Pulmonal hypertensjon søker deltakere på steder i Illinois.

Byer i Illinois

Offisiell studietekst (engelsk)

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • Northwestern University, Chicago
  • University of Illinois Health, Chicago
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06911632

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  • Northwestern University, Chicago
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07285655

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Chicago
RekruttererFase 2
Alder 18 til 85 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07333183

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Northwestern University, Chicago
  • Loyola University Medical Center, Maywood
  • Advocate Christ Medical Center, Oak Lawn
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 26. aug. 2026 · NCT06388421

Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG

  • Prairie Cardiovascular, O'Fallon
  • Prairie Education & Research Cooperative, Springfield
  • St Johns Hospital, Springfield, Springfield
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 18. jun. 2026 · NCT07087613

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  • University of Chicago, Chicago
  • Advocate Health & Hospitals Corporation, Oakbrook Terrace
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 10. jun. 2026 · NCT06526195

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.